RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 279 - per page Next page
Order by
In Vivo Non-Invasive Diagnostic Method Using Magnetic Resonance Spectroscopy of Aspartate Transaminase
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Universally Applicable Technology for Inactivation of Enveloped Viruses and Other Pathogenic Microorganisms for Vaccine Development
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
New Efficient Manufacturing Process For Biodegradable Microspheres With Controlled Release Properties For Biological Pharmaceutical Agents
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Methods for Effectively Coexpressing IL-12 and IL-23
The genes encoding immunostimulatory molecules with anti-tumoric effects include IL-2 (interleukin-2), IL-4, IL-7, IL-12. More
Use of Anthrax Lethal Factor to Treat Cancer and Screening Methods for MAPK Kinase Protease Activity
In vitro and ex vivo methods of screening for modulators, homologues, and mimetics of LF mitogen activated protein kinase kinase (MAPKK) protease activity. More
Tumour vasculant targeting agents
Novel series of heterocyclic compounds which have been tested and screened for growth inhibitory activity (IC50) against the K562 human chronic myelogenous leukemia cell-line using the MTT assay and for their ability to inhibit the tubulin assembly. More
The Hu-PAC™ Platform: Delivering the Next Generation of Fully Human Therapeutic Antibodies
The Hu-PAC™ Platform: Delivering the Next Generation of Fully Human Therapeutic Antibodies More
Development of a Cellular and Animal Model for Infantile Haemangioma
Development of a Cellular and Animal Model for Infantile Haemangioma More
Development of an HPV 59 Virus-Producing Cell Line for Drug Development
Development of an HPV 59 Virus-Producing Cell Line for Drug Development More
Rapid Identification of Responding B- or T- cells
Rapid Identification of Responding B- or T- cells More
Displaying 1..10 of 279 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Accura Animal Health Plc (ACPO) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Animal Health Products Antibacterials Markets
May 2008 - 70 pages - $1,999
Elanco Animal Health-Deals & Alliances Report
Nov 2010 - 28 pages - $600
Veterinary Diagnostics Markets
Oct 2009 - 30 pages - $995
Animal Health International, Inc. (AHII) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review
Oct 2010 - 25 pages - $250
ECO Animal Health Group plc (EAH) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Phibro Animal Health Corporation (PAHC) - Financial and Strategic SWOT Analysis Review
Apr 2011 - 26 pages - $125
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us